Apellis Pharmaceuticals, Inc. - Common Stock (APLS)

Apellis Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for the treatment of serious diseases through its expertise in complement biology

The company works on advancing its proprietary drug candidates designed to modulate the immune system, with particular attention to rare and complex conditions that currently have limited treatment options. By harnessing advanced science and technology, Apellis aims to improve patient outcomes and address unmet medical needs in various therapeutic areas, including hematology and ophthalmology.